The following conditions are highly prevalent in people with MASLD, as established by research. You are at risk of MASLD if you have any of the following conditions.
MASLD
The following conditions are highly prevalent in people with MASLD, as established by research. You are at risk of MASLD if you have any of the following conditions.
If your daily diet includes a high intake of calorie-rich foods containing sugars, fats, and carbohydrates, and you sit for long hours without any physical exercise into your routine, then you are at high risk of MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease).
Being overweight or obese especially excess weight around the tummy area (central obesity) will put you at the risk of MASLD. More than 95% of the severely obese people undergoing bariatric surgery for reducing weight are known to have MASLD.
IR is a condition where the cells do not respond to insulin hormone, which is required for the uptake and utilization of glucose (sugar) from blood for energy production
Not just metabolic syndrome, even a single feature of metabolic syndrome can raise your risk of MASLD. Metabolic syndrome is a group of disease characteristics linked to overweight and obesity.
The presence of any three or more of the following features can be considered metabolic syndrome.
If you are a type 2 diabetic, chances are high that you may have MASLD. In one study, it was found that nearly ⅓ to ⅔ of patients with type 2 diabetes have MASLD. It is a well-established fact that type 2 diabetes and MASLD are so interlinked that both can develop almost simultaneously.
“Dys” means abnormal, “lipid” means fat and “emia” means in the blood. High levels of triglycerides (a type of fat) and abnormal levels of cholesterol, with high total cholesterol, high LDL or low HDL cholesterol all contribute to risk of MASLD. Studies have shown that more than 50% of patients with dyslipidemia have MASLD.
With advancing age the risk of developing MASLD increases
It is believed that males have two times higher risk of MASLD than females
Reference:
Chalasani, N. , Younossi, Z. , Lavine, J. E., Charlton, M. , Cusi, K. , Rinella, M. , Harrison, S. A., Brunt, E. M. and Sanyal, A. J. (2018), The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67: 328-357. doi:10.1002/hep.29367